Hemato Oncology Testing Market - Global Outlook and Forecast 2021-2027

March 2021 | 91 pages | ID: H19B2536DEDBEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Hemato Oncology Testing in Global, including the following market information:

Global Hemato Oncology Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Hemato Oncology Testing market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemato Oncology Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hemato Oncology Testing Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Hemato Oncology Testing Market Segment Percentages, By Type, 2020 (%)

• ctDNA Testing
• CTC Testing
• Other Testing

China Hemato Oncology Testing Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Hemato Oncology Testing Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Third Party Agency
• Others

Global Hemato Oncology Testing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Hemato Oncology Testing Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Hemato Oncology Testing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Hemato Oncology Testing Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Roche
• Berry Genomics
• Burning Rock Dx
• BGI
• Genetron
• Haplox
• Amoy Dx
• Genosaber
• YZY Biopharma
• Wondfo

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hemato Oncology Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hemato Oncology Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEMATO ONCOLOGY TESTING OVERALL MARKET SIZE

2.1 Global Hemato Oncology Testing Market Size: 2021 VS 2027
2.2 Global Hemato Oncology Testing Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hemato Oncology Testing Players in Global Market
3.2 Top Global Hemato Oncology Testing Companies Ranked by Revenue
3.3 Global Hemato Oncology Testing Revenue by Companies
3.4 Top 3 and Top 5 Hemato Oncology Testing Companies in Global Market, by Revenue in 2020
3.5 Global Companies Hemato Oncology Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemato Oncology Testing Players in Global Market
  3.6.1 List of Global Tier 1 Hemato Oncology Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hemato Oncology Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Hemato Oncology Testing Market Size Markets, 2021 & 2027
  4.1.2 ctDNA Testing
  4.1.3 CTC Testing
  4.1.4 Other Testing
4.2 By Type - Global Hemato Oncology Testing Revenue & Forecasts
  4.2.1 By Type - Global Hemato Oncology Testing Revenue, 2016-2021
  4.2.2 By Type - Global Hemato Oncology Testing Revenue, 2022-2027
  4.2.3 By Type - Global Hemato Oncology Testing Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hemato Oncology Testing Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Third Party Agency
  5.1.4 Others
5.2 By Application - Global Hemato Oncology Testing Revenue & Forecasts
  5.2.1 By Application - Global Hemato Oncology Testing Revenue, 2016-2021
  5.2.2 By Application - Global Hemato Oncology Testing Revenue, 2022-2027
  5.2.3 By Application - Global Hemato Oncology Testing Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Hemato Oncology Testing Market Size, 2021 & 2027
6.2 By Region - Global Hemato Oncology Testing Revenue & Forecasts
  6.2.1 By Region - Global Hemato Oncology Testing Revenue, 2016-2021
  6.2.2 By Region - Global Hemato Oncology Testing Revenue, 2022-2027
  6.2.3 By Region - Global Hemato Oncology Testing Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Hemato Oncology Testing Revenue, 2016-2027
  6.3.2 US Hemato Oncology Testing Market Size, 2016-2027
  6.3.3 Canada Hemato Oncology Testing Market Size, 2016-2027
  6.3.4 Mexico Hemato Oncology Testing Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Hemato Oncology Testing Revenue, 2016-2027
  6.4.2 Germany Hemato Oncology Testing Market Size, 2016-2027
  6.4.3 France Hemato Oncology Testing Market Size, 2016-2027
  6.4.4 U.K. Hemato Oncology Testing Market Size, 2016-2027
  6.4.5 Italy Hemato Oncology Testing Market Size, 2016-2027
  6.4.6 Russia Hemato Oncology Testing Market Size, 2016-2027
  6.4.7 Nordic Countries Hemato Oncology Testing Market Size, 2016-2027
  6.4.8 Benelux Hemato Oncology Testing Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Hemato Oncology Testing Revenue, 2016-2027
  6.5.2 China Hemato Oncology Testing Market Size, 2016-2027
  6.5.3 Japan Hemato Oncology Testing Market Size, 2016-2027
  6.5.4 South Korea Hemato Oncology Testing Market Size, 2016-2027
  6.5.5 Southeast Asia Hemato Oncology Testing Market Size, 2016-2027
  6.5.6 India Hemato Oncology Testing Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Hemato Oncology Testing Revenue, 2016-2027
  6.6.2 Brazil Hemato Oncology Testing Market Size, 2016-2027
  6.6.3 Argentina Hemato Oncology Testing Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hemato Oncology Testing Revenue, 2016-2027
  6.7.2 Turkey Hemato Oncology Testing Market Size, 2016-2027
  6.7.3 Israel Hemato Oncology Testing Market Size, 2016-2027
  6.7.4 Saudi Arabia Hemato Oncology Testing Market Size, 2016-2027
  6.7.5 UAE Hemato Oncology Testing Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Hemato Oncology Testing Major Product Offerings
  7.1.4 Roche Hemato Oncology Testing Revenue in Global (2016-2021)
  7.1.5 Roche Key News
7.2 Berry Genomics
  7.2.1 Berry Genomics Corporate Summary
  7.2.2 Berry Genomics Business Overview
  7.2.3 Berry Genomics Hemato Oncology Testing Major Product Offerings
  7.2.4 Berry Genomics Hemato Oncology Testing Revenue in Global (2016-2021)
  7.2.5 Berry Genomics Key News
7.3 Burning Rock Dx
  7.3.1 Burning Rock Dx Corporate Summary
  7.3.2 Burning Rock Dx Business Overview
  7.3.3 Burning Rock Dx Hemato Oncology Testing Major Product Offerings
  7.3.4 Burning Rock Dx Hemato Oncology Testing Revenue in Global (2016-2021)
  7.3.5 Burning Rock Dx Key News
7.4 BGI
  7.4.1 BGI Corporate Summary
  7.4.2 BGI Business Overview
  7.4.3 BGI Hemato Oncology Testing Major Product Offerings
  7.4.4 BGI Hemato Oncology Testing Revenue in Global (2016-2021)
  7.4.5 BGI Key News
7.5 Genetron
  7.5.1 Genetron Corporate Summary
  7.5.2 Genetron Business Overview
  7.5.3 Genetron Hemato Oncology Testing Major Product Offerings
  7.5.4 Genetron Hemato Oncology Testing Revenue in Global (2016-2021)
  7.5.5 Genetron Key News
7.6 Haplox
  7.6.1 Haplox Corporate Summary
  7.6.2 Haplox Business Overview
  7.6.3 Haplox Hemato Oncology Testing Major Product Offerings
  7.6.4 Haplox Hemato Oncology Testing Revenue in Global (2016-2021)
  7.6.5 Haplox Key News
7.7 Amoy Dx
  7.7.1 Amoy Dx Corporate Summary
  7.7.2 Amoy Dx Business Overview
  7.7.3 Amoy Dx Hemato Oncology Testing Major Product Offerings
  7.4.4 Amoy Dx Hemato Oncology Testing Revenue in Global (2016-2021)
  7.7.5 Amoy Dx Key News
7.8 Genosaber
  7.8.1 Genosaber Corporate Summary
  7.8.2 Genosaber Business Overview
  7.8.3 Genosaber Hemato Oncology Testing Major Product Offerings
  7.8.4 Genosaber Hemato Oncology Testing Revenue in Global (2016-2021)
  7.8.5 Genosaber Key News
7.9 YZY Biopharma
  7.9.1 YZY Biopharma Corporate Summary
  7.9.2 YZY Biopharma Business Overview
  7.9.3 YZY Biopharma Hemato Oncology Testing Major Product Offerings
  7.9.4 YZY Biopharma Hemato Oncology Testing Revenue in Global (2016-2021)
  7.9.5 YZY Biopharma Key News
7.10 Wondfo
  7.10.1 Wondfo Corporate Summary
  7.10.2 Wondfo Business Overview
  7.10.3 Wondfo Hemato Oncology Testing Major Product Offerings
  7.10.4 Wondfo Hemato Oncology Testing Revenue in Global (2016-2021)
  7.10.5 Wondfo Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hemato Oncology Testing Market Opportunities & Trends in Global Market
Table 2. Hemato Oncology Testing Market Drivers in Global Market
Table 3. Hemato Oncology Testing Market Restraints in Global Market
Table 4. Key Players of Hemato Oncology Testing in Global Market
Table 5. Top Hemato Oncology Testing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Hemato Oncology Testing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Hemato Oncology Testing Revenue Share by Companies, 2016-2021
Table 8. Global Companies Hemato Oncology Testing Product Type
Table 9. List of Global Tier 1 Hemato Oncology Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hemato Oncology Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Hemato Oncology Testing Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Hemato Oncology Testing Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Hemato Oncology Testing Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Hemato Oncology Testing Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Hemato Oncology Testing Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Hemato Oncology Testing Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Hemato Oncology Testing Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Hemato Oncology Testing Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Hemato Oncology Testing Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Hemato Oncology Testing Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Hemato Oncology Testing Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Hemato Oncology Testing Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Hemato Oncology Testing Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Hemato Oncology Testing Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Hemato Oncology Testing Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Hemato Oncology Testing Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Hemato Oncology Testing Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Hemato Oncology Testing Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Hemato Oncology Testing Revenue, (US$, Mn), 2022-2027
Table 30. Roche Corporate Summary
Table 31. Roche Hemato Oncology Testing Product Offerings
Table 32. Roche Hemato Oncology Testing Revenue (US$, Mn), (2016-2021)
Table 33. Berry Genomics Corporate Summary
Table 34. Berry Genomics Hemato Oncology Testing Product Offerings
Table 35. Berry Genomics Hemato Oncology Testing Revenue (US$, Mn), (2016-2021)
Table 36. Burning Rock Dx Corporate Summary
Table 37. Burning Rock Dx Hemato Oncology Testing Product Offerings
Table 38. Burning Rock Dx Hemato Oncology Testing Revenue (US$, Mn), (2016-2021)
Table 39. BGI Corporate Summary
Table 40. BGI Hemato Oncology Testing Product Offerings
Table 41. BGI Hemato Oncology Testing Revenue (US$, Mn), (2016-2021)
Table 42. Genetron Corporate Summary
Table 43. Genetron Hemato Oncology Testing Product Offerings
Table 44. Genetron Hemato Oncology Testing Revenue (US$, Mn), (2016-2021)
Table 45. Haplox Corporate Summary
Table 46. Haplox Hemato Oncology Testing Product Offerings
Table 47. Haplox Hemato Oncology Testing Revenue (US$, Mn), (2016-2021)
Table 48. Amoy Dx Corporate Summary
Table 49. Amoy Dx Hemato Oncology Testing Product Offerings
Table 50. Amoy Dx Hemato Oncology Testing Revenue (US$, Mn), (2016-2021)
Table 51. Genosaber Corporate Summary
Table 52. Genosaber Hemato Oncology Testing Product Offerings
Table 53. Genosaber Hemato Oncology Testing Revenue (US$, Mn), (2016-2021)
Table 54. YZY Biopharma Corporate Summary
Table 55. YZY Biopharma Hemato Oncology Testing Product Offerings
Table 56. YZY Biopharma Hemato Oncology Testing Revenue (US$, Mn), (2016-2021)
Table 57. Wondfo Corporate Summary
Table 58. Wondfo Hemato Oncology Testing Product Offerings
Table 59. Wondfo Hemato Oncology Testing Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Hemato Oncology Testing Segment by Type
Figure 2. Hemato Oncology Testing Segment by Application
Figure 3. Global Hemato Oncology Testing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hemato Oncology Testing Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Hemato Oncology Testing Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hemato Oncology Testing Revenue in 2020
Figure 8. By Type - Global Hemato Oncology Testing Revenue Market Share, 2016-2027
Figure 9. By Application - Global Hemato Oncology Testing Revenue Market Share, 2016-2027
Figure 10. By Region - Global Hemato Oncology Testing Revenue Market Share, 2016-2027
Figure 11. By Country - North America Hemato Oncology Testing Revenue Market Share, 2016-2027
Figure 12. US Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Hemato Oncology Testing Revenue Market Share, 2016-2027
Figure 16. Germany Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 17. France Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Hemato Oncology Testing Revenue Market Share, 2016-2027
Figure 24. China Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 28. India Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Hemato Oncology Testing Revenue Market Share, 2016-2027
Figure 30. Brazil Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Hemato Oncology Testing Revenue Market Share, 2016-2027
Figure 33. Turkey Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Hemato Oncology Testing Revenue, (US$, Mn), 2016-2027
Figure 37. Roche Hemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Berry Genomics Hemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Burning Rock Dx Hemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. BGI Hemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Genetron Hemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Haplox Hemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Amoy Dx Hemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Genosaber Hemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. YZY Biopharma Hemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Wondfo Hemato Oncology Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)